GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioNeutra Global Corp (TSXV:BGA) » Definitions » Cyclically Adjusted Revenue per Share

BioNeutra Global (TSXV:BGA) Cyclically Adjusted Revenue per Share : C$0.67 (As of Sep. 2024)


View and export this data going back to 1999. Start your Free Trial

What is BioNeutra Global Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

BioNeutra Global's adjusted revenue per share for the three months ended in Sep. 2024 was C$0.074. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is C$0.67 for the trailing ten years ended in Sep. 2024.

During the past 12 months, BioNeutra Global's average Cyclically Adjusted Revenue Growth Rate was -5.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -3.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -1.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of BioNeutra Global was 28.20% per year. The lowest was -3.50% per year. And the median was 8.85% per year.

As of today (2024-12-15), BioNeutra Global's current stock price is C$0.03. BioNeutra Global's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 was C$0.67. BioNeutra Global's Cyclically Adjusted PS Ratio of today is 0.04.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of BioNeutra Global was 2.43. The lowest was 0.02. And the median was 0.36.


BioNeutra Global Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for BioNeutra Global's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNeutra Global Cyclically Adjusted Revenue per Share Chart

BioNeutra Global Annual Data
Trend Feb14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.80 0.76 0.73 0.72 0.69

BioNeutra Global Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.71 0.69 0.69 0.68 0.67

Competitive Comparison of BioNeutra Global's Cyclically Adjusted Revenue per Share

For the Packaged Foods subindustry, BioNeutra Global's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioNeutra Global's Cyclically Adjusted PS Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioNeutra Global's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where BioNeutra Global's Cyclically Adjusted PS Ratio falls into.



BioNeutra Global Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BioNeutra Global's adjusted Revenue per Share data for the three months ended in Sep. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.074/127.2847*127.2847
=0.074

Current CPI (Sep. 2024) = 127.2847.

BioNeutra Global Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.771 99.473 0.987
201503 0.132 99.789 0.168
201506 0.097 100.500 0.123
201509 0.049 100.421 0.062
201512 0.081 99.947 0.103
201603 0.100 101.054 0.126
201606 0.135 102.002 0.168
201609 0.174 101.765 0.218
201612 0.149 101.449 0.187
201703 0.159 102.634 0.197
201706 0.193 103.029 0.238
201709 0.194 103.345 0.239
201712 0.175 103.345 0.216
201803 0.213 105.004 0.258
201806 0.264 105.557 0.318
201809 0.182 105.636 0.219
201812 0.155 105.399 0.187
201903 0.186 106.979 0.221
201906 0.194 107.690 0.229
201909 0.223 107.611 0.264
201912 0.208 107.769 0.246
202003 0.154 107.927 0.182
202006 0.136 108.401 0.160
202009 0.126 108.164 0.148
202012 0.103 108.559 0.121
202103 0.070 110.298 0.081
202106 0.087 111.720 0.099
202109 0.082 112.905 0.092
202112 0.092 113.774 0.103
202203 0.085 117.646 0.092
202206 0.077 120.806 0.081
202209 0.071 120.648 0.075
202212 0.045 120.964 0.047
202303 0.064 122.702 0.066
202306 0.068 124.203 0.070
202309 0.057 125.230 0.058
202312 0.058 125.072 0.059
202403 0.053 126.258 0.053
202406 0.057 127.522 0.057
202409 0.074 127.285 0.074

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


BioNeutra Global  (TSXV:BGA) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

BioNeutra Global's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.03/0.67
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of BioNeutra Global was 2.43. The lowest was 0.02. And the median was 0.36.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


BioNeutra Global Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of BioNeutra Global's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


BioNeutra Global Business Description

Traded in Other Exchanges
N/A
Address
9608 - 25 Avenue NW, Edmonton, AB, CAN, T6N 1J4
BioNeutra Global Corp is engaged in the research, development, production, and commercialization of food ingredients for neutraceutical, functional and mainstream foods, focusing on oligosaccharides. Its product portfolio provides ingredients for various food systems, that contribute to human nutrition and wellness in functional and healthy foods. Its prime product, VitaFiber IMO, is offered in both powder and syrup form. The company operates in Canada while generating sales revenue from various countries internationally. It has a single industry segment, manufacturing and trading of products. The majority of the revenue is derived from the United States.
Executives
Douglas Alan Horner Director, Senior Officer
Monica Barclay Senior Officer

BioNeutra Global Headlines

No Headlines